Business Context and Reporting Period
This Form 8-K filing by International Flavors & Fragrances Inc. (IFF) reports corporate governance changes effective October 20, 2025, with the report filed on October 22, 2025. The changes stem from a previously disclosed Cooperation Agreement between IFF and the Icahn Group.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition and does not contain financial performance data.
Material Changes
Significant changes to the Board of Directors occurred on October 20, 2025:
- Departures: Mr. Vincent Intrieri (Icahn Designee) and Ms. Margarita Paláu-Hernández stepped down from the Board. Both stated their departures were not due to any disagreement with the Company, management, or the Board.
- Appointments: Mr. Brett Icahn replaced Mr. Intrieri as the Icahn Designee. Dr. Richard Mulligan replaced Ms. Paláu-Hernández as an independent director mutually acceptable to the Board and the Icahn Group.
- Committee Assignments: Mr. Icahn was named to the Audit Committee and Transaction Committee. Dr. Mulligan was named to the Innovation Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. The only risk or contingency noted is the confirmation that there are no undisclosed arrangements or material transactions involving the new directors exceeding $120,000 since the beginning of the last fiscal year, other than the Cooperation Agreement.
Key Facts for Investor Verification
- Verify the independence status of Mr. Brett Icahn and Dr. Richard Mulligan as determined by the Board under NYSE rules.
- Review the 2024 Proxy Statement (filed March 18, 2025) for details on the non-employee director compensation arrangements applicable to the new appointees.
- Confirm the terms of the Cooperation Agreement dated February 1, 2023, which governs the Icahn Group's representation on the Board.
- Note that Mr. Icahn and Dr. Mulligan have no direct or indirect material interest in transactions exceeding $120,000 with the Company since the start of the last fiscal year.